Neovascular macular degeneration is the wet form of age-related macular degeneration (AMD). It happens when new, abnormal blood vessels grow under or into the macula, the part of the retina responsible for sharp central vision. These vessels can leak blood or fluid, which may damage the macula and make straight-ahead vision blurry or distorted. It is also called wet AMD or advanced neovascular AMD.
What Does Neovascular Macular Degeneration Mean?
The term sounds complicated, but its meaning is relatively simple. "Neovascular" refers to the growth of new blood vessels. "Macular" refers to the macula, a small area near the center of the retina at the back of the eye.
The macula helps you see fine details directly in front of you. It is important for everyday activities such as reading, recognizing faces, watching television, and driving.
In neovascular macular degeneration, abnormal blood vessels develop beneath or within the macula. These vessels are fragile and may leak blood or fluid into the surrounding retinal tissue. The leakage can interfere with the macula's normal function and affect central vision.
The National Eye Institute identifies wet AMD as advanced neovascular AMD, a less common form of late-stage age-related macular degeneration.
How Does Neovascular Macular Degeneration Develop?
The retina contains light-sensitive cells that send visual information to the brain. The macula contains a high concentration of these cells, allowing you to see fine details clearly.
Behind the retina is a layer of blood vessels called the choroid. These vessels normally supply nutrients and oxygen to the eye's tissues.
In neovascular macular degeneration, abnormal new blood vessels grow from the choroid beneath or into the macula. This process is called choroidal neovascularization.
A protein called vascular endothelial growth factor (VEGF) encourages blood vessel growth. In wet AMD, VEGF contributes to the development of abnormal vessels in the back of the eye.
These new vessels can leak fluid or blood. The leakage may cause swelling and changes in the structure of the macula, making central vision less clear. Over time, damage to this area can affect the ability to see fine details.
According to Mayo Clinic, abnormal blood vessel growth and fluid leakage are important features of wet macular degeneration.
Is Neovascular Macular Degeneration the Same as Wet AMD?
Yes. Neovascular macular degeneration is another name for wet age-related macular degeneration. The terms describe the same advanced form of AMD.
Age-related macular degeneration has two main forms:
Dry macular degeneration
Dry AMD is the more common form. It develops when the macula gradually becomes thinner and changes with age. Small deposits called drusen may also collect beneath the retina. Vision changes usually develop slowly, although the rate of progression varies.
Wet macular degeneration
Wet AMD is less common but can cause faster changes in central vision. It develops when abnormal blood vessels grow beneath or into the macula and begin leaking blood or fluid.
Wet AMD is always classified as late-stage AMD. It can develop from dry AMD, including when an eye previously had an earlier stage of the condition.
According to MedlinePlus, dry AMD generally causes slower vision changes, while wet AMD can damage the macula more quickly because of abnormal blood vessel growth and leakage.
What Are the Effects of Neovascular Macular Degeneration on Vision?
The main effect is a change in central vision. Since the macula is responsible for seeing details directly ahead, damage to this area can make everyday visual tasks more difficult.
Some experiences associated with wet macular degeneration include:
- Blurry central vision: Objects directly in front of you may appear unclear.
- Distorted straight lines: Straight objects, such as doorframes or window edges, may appear bent, wavy, or crooked.
- Dark or blank spots: A blurred or missing area may develop near the center of the field of vision.
- Difficulty reading: Printed words may become harder to recognize or appear distorted.
- Difficulty recognizing faces: Details in people's faces may become less clear.
- Changes in low-light vision: Seeing details in dimly lit places may become more difficult.
- Reduced color clarity: Colors may appear less bright than before.
These changes can affect one or both eyes. Wet macular degeneration primarily affects central vision rather than side vision, so it does not usually cause complete blindness.
Mayo Clinic's information on wet macular degeneration describes these visual changes and notes that symptoms may appear suddenly and worsen quickly.
How Is Neovascular Macular Degeneration Diagnosed?
An ophthalmologist, particularly a retina specialist, can evaluate the macula and determine whether abnormal blood vessels or fluid are present.
Diagnosis usually involves a comprehensive eye examination and imaging tests. Depending on the findings, the evaluation may include:
- Dilated eye examination: Eye drops widen the pupils so the doctor can examine the retina and macula for abnormalities.
- Optical coherence tomography (OCT): This painless imaging test produces detailed cross-sectional pictures of the retina. It helps identify fluid buildup, swelling, and structural changes.
- Fluorescein angiography: A special dye is injected into a vein in the arm. A camera then captures images of the retinal blood vessels to identify abnormal blood vessel growth or leakage.
- OCT angiography: This imaging technique provides detailed pictures of blood vessels in and around the retina without requiring an injected dye.
These tests help the specialist identify the type and extent of macular changes and determine whether treatment is appropriate. The Mayo Clinic guide to wet macular degeneration diagnosis describes these examination and imaging methods.
Can Neovascular Macular Degeneration Be Treated?
Yes. Treatments are available to slow or stop further vision loss from wet macular degeneration. The main treatment is a group of medicines called anti-VEGF drugs.
Anti-VEGF eye injections
Anti-VEGF medicines block the effects of signals that encourage abnormal blood vessel growth. This helps reduce leakage and bleeding from the affected vessels.
The medicine is injected directly into the affected eye by an eye specialist. Numbing medication and antiseptic measures are used during the procedure to improve comfort and reduce infection risk.
These injections are usually repeated because their effects last for a limited period. Many people initially need frequent injections, with the schedule adjusted according to how the eye responds.
Anti-VEGF treatment may help preserve existing vision, slow disease progression, and sometimes improve vision that has already been affected.
Photodynamic therapy
Photodynamic therapy (PDT) is another treatment option, although it is used less often than anti-VEGF injections.
During this procedure, a light-sensitive medicine called verteporfin is injected into a vein. The medicine travels through the bloodstream to the abnormal blood vessels in the eye. A specially directed laser activates the medicine and helps close the targeted vessels, reducing leakage.
In selected cases, photodynamic therapy may be used alongside anti-VEGF treatment.
The National Eye Institute's treatment guide for wet AMD identifies anti-VEGF injections as the most common treatment and photodynamic therapy as a less commonly used option.
When Should You See an Eye Specialist?
New or sudden changes in central vision should be evaluated promptly, particularly when straight lines begin to look wavy or distorted. Wet macular degeneration can progress quickly, and early assessment allows an eye specialist to identify changes and discuss appropriate treatment.
Do not wait for a routine eye examination if you notice a sudden change in your ability to see fine details or a new blurry or blank area in your central vision. An ophthalmologist or retina specialist can determine whether these changes are related to macular degeneration or another eye condition.
Timely diagnosis and appropriate treatment are important for protecting the vision that remains.